|
|
Article: Neurocrine Biosciences Presents Six Indiplon Studies at the Associated Professional Sleep Societies (APSS) Meeting.
- Article from:
- PR Newswire
- Article date:
- June 7, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Results Demonstrate Indiplon Significantly Improves Sleep Initiation and Sleep Maintenance
Neurocrine Biosciences, Inc. announced today that six studies from Phase I, II and III clinical trials with both formulations of indiplon will be presented at the Associated Professional Sleep Societies (APSS) Meeting, June 5-10, 2004 in Philadelphia, PA. The studies demonstrate that two formulations of indiplon, an immediate release capsule and a modified release tablet, can help patients with insomnia fall asleep faster and stay asleep longer without experiencing next-day residual effects.
"These data being presented further reinforce the robustness of the ...